Stock screenerAll disclosures →
EDGAR →
GH
Conviction 83HealthcareScan · Tue, Sep 8, 2026GH$161.01-0.25%
ResistanceSupportVol 14Insider buyInsider sellCongress buyCongress sell3
5
4
2
4
2
2
Vol MA14 1.97M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
WSB mentions · 24h changelatest +100.00%· 2 mentions
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price161.01
Change-0.25%
Gap+2.40%
Rel volume1.15×
Avg volume2.08M
Avg $ vol339M
SMA 20163.48
SMA 50159.76
SMA 200117.71
Price vs 50+0.79%
Price vs 200+36.78%
MA stackbullish
50/200 cross—
Supertrendup · 148.33
RSI (14)50
MACD hist-1.05
MACD crossbear · 6d
Stoch %K / %D37 / 36
ADX (14)20
+DI / −DI21 / 19
RSI divergenceBearish
MACD divergenceBearish
ATR %+4.95%
ADR %4.49%
52w high170.92
52w low54.79
From 52w high-5.80%
Above 52w low+193.87%
New 52w highNo
SqueezeOn · 9d
Bollinger width8.99%
%B0.33
Donchian pos36.57%
Donchian high173.17
Donchian low154.00
AVWAP (52w high)163.23
vs AVWAP high-1.36%
AVWAP (52w low)110.63
vs AVWAP low+45.54%
OBV trendFlat
Chaikin MF (20)-0.05
Today vs 20d1.15×
Avg vol (14d)1.97M
Avg vol (20d)2.08M
Avg $ vol (20d)339M
Market cap21.61B
RS 3m (vs SPY)+24.08%
RS 6m (vs SPY)+62.44%
RS line new highNo
Trend template8/8
Technical rank71.9
1 week+1.25%
1 month-4.43%
3 months+28.92%
6 months+76.55%
1 year+167.77%
YTD+58.26%
P/E-51.91
P/B-96.95
P/S22.00
P/FCF-92.71
EPS-3.32
Div yield—
ROE186.78%
ROA-21.77%
Debt/Eq-6.74
Current4.03
EV/EBITDA-55.49
Gross margin—
Net margin-42.39%
Rev growth32.88%
EPS growth4.61%
Price target194.50
Target upside20.80%
Analyst ratingBuy
Institutional110.86%
Ent. value22.06B
Revenue334.98M
Net income-120.14M
Gross profit—
Free cash flow-233.07M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out132.6M
Employees2.51K
ListedThu, Oct 4, 2018
Free float126.19M
Float %96.2%
Short interest11.19M
Days to cover5.7d
Short volume50.2%
Squeeze score52 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.89 vs −$0.74
Last surprise-20.3% miss
Setup gradeA
Conviction83 / 100
Pattern quality—
Tech rank71.9 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance174.88
Support142.86
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GH · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Sheldon Whitehouse senate · D · RI · traded 2025-11-21 | Buy | $1K–$15K | 2025-11-21 | 2025-12-01 |
Insider activity
SEC Form 4 transactions in GH · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Eltoukhy Helmy Co-Chief Executive Officer · Common Stock · 2026-08-26 | Gift | 30K | — | 2026-08-26 | 2026-08-27 |
Eltoukhy Helmy Co-Chief Executive Officer · Common Stock · 2026-08-26 | Acquire | 25K | — | 2026-08-26 | 2026-08-27 |
Eltoukhy Helmy Co-Chief Executive Officer · Common Stock · 2026-08-26 | Dispose | 25K | — | 2026-08-26 | 2026-08-27 |
Talasaz AmirAli Co-Chief Executive Officer · Common Stock · 2026-08-21 | Sell | 7.59K | $1.3M | 2026-08-21 | 2026-08-24 |
MIGNONE ROBERTO Director · Restricted Stock Units · 2026-08-21 | Exercise | 264 | — | 2026-08-21 | 2026-08-24 |
MIGNONE ROBERTO Director · Common Stock · 2026-08-21 | Exercise | 264 | — | 2026-08-21 | 2026-08-24 |
Talasaz AmirAli Co-Chief Executive Officer · Common Stock · 2026-08-21 | Sell | 9.02K | $1.5M | 2026-08-21 | 2026-08-24 |
Talasaz AmirAli Co-Chief Executive Officer · Common Stock · 2026-08-21 | Sell | 20.89K | $3.5M | 2026-08-21 | 2026-08-24 |
Hidalgo Medina Manuel Director · Common Stock · 2026-08-17 | Exercise | 232 | — | 2026-08-17 | 2026-08-18 |
Hidalgo Medina Manuel Director · Restricted Stock Units · 2026-08-17 | Exercise | 232 | — | 2026-08-17 | 2026-08-18 |
SEC filings
EDGAR filings in GH · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.